Filing Details
- Accession Number:
- 0001140361-18-029484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-21 17:02:38
- Reporting Period:
- 2018-06-19
- Accepted Time:
- 2018-06-21 17:02:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612312 | H. Joshua Bilenker | C/O Loxo Oncology, Inc. 281 Tresser Boulevard, 9Th Floor Stamford CT 06901 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-08 | 5,000 | $0.00 | 127,707 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2018-06-19 | 7,500 | $1.18 | 135,207 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-19 | 2,336 | $176.20 | 132,871 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-19 | 3,427 | $177.06 | 129,444 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-19 | 1,737 | $178.12 | 127,707 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-19 | 8,232 | $177.44 | 41,768 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Common Stock | Disposition | 2018-06-19 | 8,763 | $178.30 | 33,005 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Common Stock | Disposition | 2018-06-19 | 3,902 | $179.83 | 29,103 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Common Stock | Disposition | 2018-06-19 | 103 | $180.34 | 29,000 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Common Stock | Acquisiton | 2018-06-20 | 28,000 | $1.18 | 155,707 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-06-20 | 7,500 | $1.18 | 163,207 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-20 | 2,700 | $178.81 | 160,507 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-20 | 4,370 | $179.37 | 156,137 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-20 | 430 | $180.90 | 155,707 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-20 | 11,336 | $178.94 | 17,664 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Common Stock | Disposition | 2018-06-20 | 9,664 | $179.77 | 8,000 | No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
| No | 4 | S | Indirect | By Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-06-19 | 7,500 | $0.00 | 7,500 | $1.18 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-06-20 | 28,000 | $0.00 | 28,000 | $1.18 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-06-20 | 7,500 | $0.00 | 7,500 | $1.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 144,432 | 2023-11-14 | No | 4 | M | Direct | |
| 116,432 | 2023-11-14 | No | 4 | M | Direct | |
| 108,932 | 2023-11-14 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $175.60 to $176.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $176.64 to $177.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $177.67 to $178.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $177.00 to $177.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Joshua H. Bilenker, Trustee for the Joshua H. Bilenker 2017 GRAT u/a DTD 06/16/17 previously reported as held directly pursuant to Rule 16a-13.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $178.03 to $179.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $179.20 to $180.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $180.23 to $180.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $178.08 to $179.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $179.09 to $180.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $180.85 to $180.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $178.50 to $179.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $179.50 to $180.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The options have fully vested and are immediately exercisable.
- Option exercises that were previously reported by the Reporting Person were attributed to a single option grant in each prior Form 4 filed by the Reporting Person with the Securities and Exchange Commission. This Form 4 combines two option grants with identical terms and reports the respective option exercises in the aggregate on one row. The shares reported in this column as beneficially owned following the reported transaction represents the outstanding shares underlying both option grants.
Billionaire Hedge Funds
